PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Journal of Cell Science1 citations

Hyperactive microtubule binding of RP1L1 (R45W) underlies retinal degeneration and is suppressed by glycerol

View Full Paper
YYYuqi YeZGZhengyang GuoWLWei Li

Key Points

  • This research aims to understand how the RP1L1 R45W mutation causes retinal degeneration through hyperactive microtubule binding.
  • Live-cell imaging to measure microtubule binding
  • Molecular dynamics simulations to analyze interactions
  • Biochemical experiments to test glycerol's effects on binding
  • RP1L1 R45W shows approximately double the microtubule binding compared to wild-type RP1L1
  • Glycerol disrupts the hyper-binding of RP1L1 R45W, restoring normal microtubule interactions
  • Potential for glycerol to be a therapeutic strategy for RP1L1-related retinopathies

Abstract

Photoreceptors rely on microtubule (MT)-based transport within the connecting cilium to maintain cellular homeostasis. Mutations in RP1L1, a retina-specific doublecortin (DC) domain protein, cause inherited retinal disorders including occult macular dystrophy (OMD), yet the underlying mechanisms remain poorly defined. Here, we show that the RP1L1 R45W variant, prevalent in East Asian OMD patients, confers a toxic gain-of-function phenotype characterized by abnormally strong MT binding. Live-cell imaging revealed approximately a twofold increase in MT association relative to wild-type RP1L1. Molecular dynamics simulations indicated that R45W stabilizes RP1L1–α-tubulin interactions via cation–π contacts and reduced electrostatic repulsion. Remarkably, low concentrations of glycerol selectively disrupted these aberrant interactions, restoring MT binding to wild-type levels in both cellular and biochemical contexts. Our study elucidates a structural and mechanistic basis for RP1L1 (R45W) hyper-binding and demonstrates that small-molecule modulation of DC-domain interactions may provide a mutation-specific therapeutic strategy for RP1L1-related retinopathies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ye et al. (2026) studied this question.

synapsesocial.com/papers/6971bd26642b1836717e1d03https://doi.org/10.1242/jcs.264447
Ask AI
Helpful
Bookmark
Share
View Full Paper